Hyperthermic biology and cancer therapies: A hypothesis for the "Lance Armstrong effect"

JAMA

Volumn 296, Issue 4, 2006, Pages 445-448

  Coffey, Donald S ^a,b   Getzenberg, Robert H ^a,b   Deweese, Theodore L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL MATURATION; CELL NUCLEUS; COLON CANCER; EPIGENETICS; ESOPHAGUS CANCER; EVOLUTION; HEAT; HYPERTHERMIA; IMMUNITY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; STEM CELL;

EID: 33746456976     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.4.445     Document Type: Note

References (27)

1. Dewhirst MW, Vujaskovic Z, Jones E, Thrall D. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia. 2005;21:779-790.
2. Hahn GM, Braun J, Har-Kedar I. Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci U S A. 1975;72:937-940.
3. Ferguson MW, Joanen T. Temperature of egg incubation determining sex in alligator mississippiensis. Nature. 1982;296:850-853.
4. Guan K, Nayernia K, Maier LS, et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature. 2006;440:1199-1203.
5. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science. 1975;188:166-168.
6. Greisman LA, Mackowiak PA. Fever: beneficial and detrimental effects of antipyretics. Curr Opin Infect Dis. 2002;15:241-245.
7. Chen Q, Fisher DT, Kucinska SA, Wang WC, Evans SS. Dynamic control of lymphocyte trafficking by feber-range thermal stress. Cancer Immunol Immunother. 2006;55:299-311.
8. Ito A, Honda H, Kobayashi T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother. 2006;55:320-328.
9. Vertrees RA, Zwischenberger JB, Boor PJ, Pencil SD. Oncogenic ras results in increased cell kill due to defective thermoprotection in lung cancer cells. Ann Thorac Surg. 2000;69:1675-1680.
10. Rylander MN, Feng Y, Bass J, Diller KR. Thermally induced injury and heatshock protein expression in cells and tissues. Ann N Y Acad Sci. 2006;1066:222-242.
11. Roti Roti JL, Kampinga HH, Malyapa RS, Wright WD, vanderWaal RP, Xu M. Nuclear matrix as a target for hyperthermic killing of cancer cells. Cell Stress Chaperones. 1998;3:245-255.
12. Lepock JR, Frey HE, Heynen ML, Senisterra GA, Warters RL. The nuclear matrix is a thermolabile cellular structure. Cell Stress Chaperones. 2001;6:136-147.
13. Pienta KJ, Partin AW, Coffey DS. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res. 1989;49:2525-2532.
14. Vogelstein B, Pardoll DM, Coffey DS. Supercoiled loops and eukaryotic DNA replication. Cell. 1980;22:79-85.
15. Takaha N, Hawkins AL, Griffin CA, Isaacs WB, Coffey DS. High mobility group protein I (4): a candidate architectural protein for chromosomal rearrangements. Cancer Res. 2002;62:647-651.
16. Ciejek EM, Tsai MJ, O'Malley BW. Actively transcribed genes are associated with the nuclear matrix. Nature. 1983;306:607-609.
17. Dynlacht JR, Earles M, Henthorn J, Seno JD. Different patterns of DNA fragmentation and degradation of nuclear matrix proteins during apoptosis induced by radiation, hyperthermia or etoposide. Radiat Res. 2000;154:515-530.
18. Barone JG, Christiano AP, Ward WS. DNA organization in patients with a history of cryptorchidism. Urology. 2000;56:1068-1070.
19. Getzenberg RH, Coffey DS. Tissue specificity of the hormonal response in sex accessory tissue is associated with nuclear matrix protein patterns. Mol Endocrinol. 1990;4:1336-1342.
20. Getzenberg RH, Pienta KJ, Huang EYW, Coffey DS. Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res. 1991;51:6514-6520.
21. Paul B, Dhir R, Landsittel D, Hitchens MR, Getzenberg RH. Detection of prostate cancer with a blood-based assay for EPCA. Cancer Res. 2005;65:4097-4100.
22. Westermann AM, Jones EL, Schem BC, et al. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer. 2005;104:763-770.
23. Brizel DM, Scully SP, Harrelson JM, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 1996;56:5347-5350.
24. Lupold SE, Hicke BJ, Lin Y, Coffey DS. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 2002;62:4029-4033.
25. Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 2004;64:7668-7672.
26. di Pietro A, Vries EG, Gietema JA, Spierings DC, de Jong S. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol. 2005;37:2437-2456.
27. Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet. 2006;367:754-765.